Protease inhibitor-associated increased risk of preterm delivery is an immunological complication of therapy [2]

Journal of Infectious Diseases

Volumn 195, Issue 6, 2007, Pages 914-916

  Fiore, Simona ^a   Ferrazzi, Enrico ^a   Newell, Marie Louise ^b   Trabattoni, Daria ^a   Clerici, Mario ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 2; PHYTOHEMAGGLUTININ; PROTEINASE INHIBITOR;

CD4 LYMPHOCYTE COUNT; CYTOKINE PRODUCTION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; LETTER; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; RISK FACTOR; VIRUS LOAD;

DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV PROTEASE INHIBITORS; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREMATURE BIRTH; STILLBIRTH;

EID: 33847652904     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/511983     Document Type: Letter

References (10)

1. Cotter AM, Gonzalez Garcia A, Duthely ML, Luke B, O'Sullivan MJ. Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth? J Infect Dis 2006; 193:1195-201.
2. Hill JA. Immunological mechanisms of pregnancy maintenance and failure: a critique of theories and therapy. Am J Reprod Immunol 1990; 22:33-7.
3. Wegmann TG, Lin H, Guilbert L, Mosman TL. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14:353-9.
4. Marzi M, Viganò A, Trabattoni D, et al. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996; 106:127-33.
5. Chaouat G, Meliani AA, Martal J, et al. IL-10 prevents naturally occurring fetal loss in the CBA × DBA/2 mating combination, and local defect in IL-10 production in this abortion-prone combination is corrected by in vivo injection of IFN-tau. J Immunol 1995; 154:4261-8.
6. Kwak-Kim JYH, Chung-Bang HS, Ng SC, et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 2003; 18:767-73.
7. Petroff MG, Chen L, Phillips TA, Azzola D, Sedlmayr P, Hunt JS. B7 family molecules are favorably positioned at the human maternal-fetal interface. Biol Reprod 2003; 68:1496-504.
8. Dong HD, Zhu G, Tamada K, Chen LP. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 1999; 5:1365-9.
9. Clerici M, Shearer GM. Is HIV infection associated with a TH1→TH2 switch? Immunol Today 1993; 14:107-11.
10. Fiore S, Newell ML, Trabattoni D, et al. Antiretroviral therapy-associated modulation of Th-1 and Th-2 immune responses in HIV-infected pregnant women. J Reprod Immunol 2006; 70:143-50.